Assessment of Reactance Parameters Measured by the Forced Oscillation Technique for the Bronchodilator Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Launched by CENTRE HOSPITALIER UNIVERSITAIRE UCLOUVAIN NAMUR · Apr 9, 2019
Trial Information
Current as of April 27, 2025
Unknown status
Keywords
ClinConnect Summary
Different techniques will be used during this study :
First, the FOT. The measurements will be performed using a Tremoflo-type (Thorasys Thoracic Medical System Inc.) device that generates an oscillating pressure waveform and measures impedance of the respiratory system and its components (resistance and reactance) as a function of frequency, as well as the respiratory system resonant frequency. Measurements will be performed during tidal breathing, the subjects breathing through the pneumotachograph of the system, with nose occluded, the cheeks supported by the hands (of the subjects or o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of COPD confirmed by post-bronchodilator (DUOVENT HFA 4 puffs) obstructive airway obstruction (FEV1/Forced Vital Capacity \< Percentile 5) persisting after bronchodilatation
- • Former or active smoking \> 10 packs/year
- • Age \> 40 years
- • Informed consent
- Exclusion Criteria:
- * Inability to comply with bronchodilator weaning time :
- • 6 hours for short-acting bronchodilators ; 12 hours for long-acting bronchodilators ; 24 hours for very long-acting bronchodilators
- • Inability to comply with the 4 hours of smoking cessation before the measurements
- • Inability to perform respiratory function tests
- • Continuous oxygen therapy
- • Close angle glaucoma
- • History of urinary retention (only for patients not usually treated with anticholinergic bronchodilators)
- • Pregnancy
- • Acute illness contraindicating the performance of respiratory tests
About Centre Hospitalier Universitaire Uclouvain Namur
The Centre Hospitalier Universitaire UCLouvain Namur is a leading academic hospital in Belgium, dedicated to advancing healthcare through innovative clinical research and patient care. Affiliated with UCLouvain, a prestigious university, the institution fosters a collaborative environment that integrates cutting-edge medical research with clinical practice. The hospital is committed to improving patient outcomes by conducting a diverse range of clinical trials, focusing on various medical specialties. Through its robust infrastructure and multidisciplinary teams, the Centre Hospitalier Universitaire UCLouvain Namur aims to contribute significantly to medical science and enhance the quality of life for patients in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials